This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Location:Geneva, Switzerland
Organized by:International Alliance for Biological Standardisation and the World Health Organization
As part of the 10-year anniversary events, ECDC hosted a scientific seminar to discuss some of the pressing public health challenges to Europe, such as antimicrobial resistance and influenza.
Professor Mike Catchpole, Chief Scientist of ECDC, presented to the Environment, Public Health and Food Safety Committee of the European Parliament during an exchange of views on vaccination.
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.
Neuraminidase inhibitors, commonly referred to as antivirals, have been subject to much debate about the effectiveness in preventing and treating influenza. ECDC convened a meeting of experts in order to review and discuss evidence regarding antivirals.
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
The objective for this meeting between ECDC and influenza vaccine manufacturers was to share latest information on influenza disease monitoring including severe disease, monitoring of seasonal influenza vaccination programmes in the EU and new technical developments for improved influenza vaccines.